HKU Scholars Hub: Browsing DSpace

Browsing by Author TSANG, FH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 20 of 25 next >

Title	Author(s)	Issue Date
Aberrant super-enhancer landscape in human hepatocellular carcinoma Journal:Hepatology	Tsang, FH Law, CT Tang, TCC Cheng, CL Chin, DW Tam, WSV Wei, L Wong, CCL Ng, IOL Wong, CM	2019
Application of image-guided biopsy for impalpable breast lesions in Chinese women Journal:ANZ Journal of Surgery	Tsang, FH Lo, JJ Wong, JL Lee, FC Chow, LWC	2003
Chromatin remodeler HELLS is an epigenetic driver for hepatocellular carcinoma progression Proceeding/Conference:Cancer Research	Law, CT Wei, LL Tsang, FH Chan, CY Xu, MJI Lai, RK Ho, DWH Lee, JKM Wong, CCL Ng, IOL Wong, CM	2017
Clinical implication of ectopic expression of microRNA-125b in liver cancer Proceeding/Conference:Cancer Omics	Tsang, FH Luk, JMC Lee, NPY	2010
Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma Journal:Oncogene	Fatima, S Lee, NP Tsang, FH Kolligs, FT Ng, IOL Poon, RTP Fan, ST Luk, JM	2012
Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis Journal:Hepatology	Au, LKS Wong, CCL Lee, MF Fan, NY Tsang, FH Ng, IOL Wong, CM	2012
Expression of ankyrin repeat and SOCS box containing 4 (ASB4) confers migration and invasion properties of hepatocellular carcinoma cells Journal:BioScience Trends	Au, CHV TSANG, FH Man, K Fan, ST Poon, RTP Lee, NPY	2014
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma Journal:Journal of Clinical Investigation	LEE, D XU, M CHIU, KC LAI, KH Tse, PW Li, LL LAW, CT Tsang, FH Wei, L CHAN, YK Wong, CM Ng, IOL Wong, CCL	2017
Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer Journal:Oncogenesis	Tse, AP Sze, KM Shea, QT Chiu, EY Tsang, FH Chiu, DK Zhang, MS Lee, D Xu, IM Chan, CY Koh, HY Wong, CM Zheng, YP Ng, IOL	2018
Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b Journal:Hepatology	Fan, NY Tsang, FH Tam, HKA Au, LKS Wong, CCL Wei, L Lee, MF He, XH Ng, IOL Wong, CM	2013
Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3 Journal:Journal of Hepatology	Wei, L Chiu, KC Tsang, FH Law, CT Cheng, LHC Au, LKS Lee, MF Wong, CCL Ng, IOL Wong, CM	2017
Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma Journal:Nature Communications	CHIU, KC Tse, PW XU, M Cui, D LAI, KH Li, LL Koh, HY Tsang, FH WEI, L Wong, CM Ng, IOL Wong, CCL	2017
In vivo genome-wide CRISPR activation screening identifies functionally important long non-coding RNAs in hepatocellular carcinoma. Journal:Cell Mol Gastroenterol Hepatol	WONG, LS Wei, L WANG, G LAW, CT Tsang, FH Chin, WC Ng, IOL Wong, CM	2022
Lysyl Oxidase-like 2 Is Critical To Tumor Microenvironment And Metastatic Niche Formation In Hepatocellular Carcinoma Journal:Hepatology	Wong, CCL Tse, PW Huang, Y Zhu, Y CHIU, KC LAI, KH Au, LKS Kai, AKL Lee, MF WEI, L Tsang, FH Lo, CLR Shi, J Zheng, Y Wong, CM Ng, IOL	2014
MicroRNA-125b as a negative regulator for eukaryotic translation initiation factor 5A2 (eIF5A2) in liver cancer Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2009 and 6th RCC Annual Meeting	Tsang, FH Luk, JMC Lee, NPY	2009
MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility Journal:Frontiers of Medicine	Tsang, FH Au, LKS Wei, L Fan, NY Lee, MF Wong, CCL Ng, IOL Wong, CM	2015
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications Journal:Nature Reviews Gastroenterology & Hepatology	Wong, CM Tsang, FH Ng, IOL	2018
Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2 Journal:Digestive Diseases and Sciences	TSANG, FH Au, CHV LU, W SHEK, HP LIU, ML Luk, JMC Fan, ST Poon, RTP Lee, NPY	2014
Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma Journal:International Journal of Cancer	Lee, NP Tsang, FH Shek, FH Mao, M Dai, H Zhang, C Dong, S Guan, XY Poon, RTP Luk, JM	2010
Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma Journal:Journal of Proteome Research	Lee, NP Chen, L Lin, MC Tsang, FH Yeung, C Poon, RT Peng, J Leng, X Beretta, L Sun, S Day, PJ Luk, JM	2009

Showing results 1 to 20 of 25 next >